Posts

With Voxzogo under pressure, BioMarin touts trial win in label expansion bid

on

Astellas Submits Supplemental New Drug Application in Japan for PADCEV (Enfortumab Vedotin) + Keytruda (Pembrolizumab) for Muscle-Invasive Bladder Cancer

on

Insmed's Arikayce Achieves Phase 3 Success in MAC Lung Disease, Paving Way for Label Expansion and Potential Blockbuster Status

on

BioXcel Therapeutics Expands Leadership Team with Mark Pavao as Acting Chief Commercial Officer

on

Vanda Ends Lawsuits Against FDA in Broad Settlement, Paving Way for Drug Review Progress

on

FDA Rejects Lundbeck and Otsuka's Rexulti for PTSD on Insufficient Efficacy Evidence

on

Federal Appeals Court Overturns FDA Rejection of Vanda’s Hetlioz for Jet Lag Disorder

on